Exact Mass: 522.392

Exact Mass Matches: 522.392

Found 59 metabolites which its exact mass value is equals to given mass value 522.392, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DG(10:0/18:2(10E,12Z)+=O(9)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C31H54O6 (522.392)

DG(10:0/18:2(10E,12Z)+=O(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/18:2(10E,12Z)+=O(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(18:2(10E,12Z)+=O(9)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C31H54O6 (522.392)

DG(18:2(10E,12Z)+=O(9)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(10E,12Z)+=O(9)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/18:2(10E,12Z)+=O(9))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C31H54O6 (522.392)

DG(10:0/0:0/18:2(10E,12Z)+=O(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(18:2(10E,12Z)+=O(9)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C31H54O6 (522.392)

DG(18:2(10E,12Z)+=O(9)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/18:2(9Z,11E)+=O(13)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C31H54O6 (522.392)

DG(10:0/18:2(9Z,11E)+=O(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/18:2(9Z,11E)+=O(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(18:2(9Z,11E)+=O(13)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C31H54O6 (522.392)

DG(18:2(9Z,11E)+=O(13)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(9Z,11E)+=O(13)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/18:2(9Z,11E)+=O(13))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C31H54O6 (522.392)

DG(10:0/0:0/18:2(9Z,11E)+=O(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(18:2(9Z,11E)+=O(13)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C31H54O6 (522.392)

DG(18:2(9Z,11E)+=O(13)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/18:3(10,12,15)-OH(9)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C31H54O6 (522.392)

DG(10:0/18:3(10,12,15)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/18:3(10,12,15)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(18:3(10,12,15)-OH(9)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C31H54O6 (522.392)

DG(18:3(10,12,15)-OH(9)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(10,12,15)-OH(9)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/18:3(10,12,15)-OH(9))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C31H54O6 (522.392)

DG(10:0/0:0/18:3(10,12,15)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(18:3(10,12,15)-OH(9)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C31H54O6 (522.392)

DG(18:3(10,12,15)-OH(9)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/18:3(9,11,15)-OH(13)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C31H54O6 (522.392)

DG(10:0/18:3(9,11,15)-OH(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/18:3(9,11,15)-OH(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(18:3(9,11,15)-OH(13)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C31H54O6 (522.392)

DG(18:3(9,11,15)-OH(13)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(9,11,15)-OH(13)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/18:3(9,11,15)-OH(13))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C31H54O6 (522.392)

DG(10:0/0:0/18:3(9,11,15)-OH(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(18:3(9,11,15)-OH(13)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C31H54O6 (522.392)

DG(18:3(9,11,15)-OH(13)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/20:3(6,8,11)-OH(5)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C31H54O6 (522.392)

DG(8:0/20:3(6,8,11)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:3(6,8,11)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(6,8,11)-OH(5)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C31H54O6 (522.392)

DG(20:3(6,8,11)-OH(5)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(6,8,11)-OH(5)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/20:3(6,8,11)-OH(5))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C31H54O6 (522.392)

DG(8:0/0:0/20:3(6,8,11)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(6,8,11)-OH(5)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C31H54O6 (522.392)

DG(20:3(6,8,11)-OH(5)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

(+)-(20S)-20-(dimethylamino)-3alpha-(methylbenzoylamino)-5alpha-pregn-12beta-yl acetate

C33H50N2O3 (522.3821)

aglinin B methyl ester

C31H54O6 (522.392)

DG(10:0/18:2(10E,12Z)+=O(9)/0:0)

C31H54O6 (522.392)

DG(18:2(10E,12Z)+=O(9)/10:0/0:0)

C31H54O6 (522.392)

DG(10:0/0:0/18:2(10E,12Z)+=O(9))

C31H54O6 (522.392)

DG(18:2(10E,12Z)+=O(9)/0:0/10:0)

C31H54O6 (522.392)

DG(10:0/18:2(9Z,11E)+=O(13)/0:0)

C31H54O6 (522.392)

DG(18:2(9Z,11E)+=O(13)/10:0/0:0)

C31H54O6 (522.392)

DG(10:0/0:0/18:2(9Z,11E)+=O(13))

C31H54O6 (522.392)

DG(18:2(9Z,11E)+=O(13)/0:0/10:0)

C31H54O6 (522.392)

[(2S)-1-hydroxy-3-octanoyloxypropan-2-yl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

C31H54O6 (522.392)

[(2S)-3-hydroxy-2-octanoyloxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

C31H54O6 (522.392)

[(2R)-2-hydroxy-3-octanoyloxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

C31H54O6 (522.392)

[(2S)-2-hydroxy-3-octanoyloxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

C31H54O6 (522.392)

[(2S)-1-decanoyloxy-3-hydroxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C31H54O6 (522.392)

[(2S)-2-decanoyloxy-3-hydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C31H54O6 (522.392)

[(2R)-3-decanoyloxy-2-hydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C31H54O6 (522.392)

[(2S)-3-decanoyloxy-2-hydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C31H54O6 (522.392)

[(2S)-1-decanoyloxy-3-hydroxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C31H54O6 (522.392)

[(2S)-2-decanoyloxy-3-hydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C31H54O6 (522.392)

[(2R)-3-decanoyloxy-2-hydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C31H54O6 (522.392)

[(2S)-3-decanoyloxy-2-hydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C31H54O6 (522.392)

2-[hydroxy-[(2R)-2-methoxy-3-[(Z)-octadec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C27H57NO6P+ (522.3923)

2-[hydroxy-[2-hydroxy-3-[(Z)-nonadec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C27H57NO6P+ (522.3923)

TG(28:2)

TG(8:0_8:0_12:2)

C31H54O6 (522.392)

NA-Trp 22:2(13Z,16Z)

C33H50N2O3 (522.3821)

ST 25:0;O;Hex

C31H54O6 (522.392)

(4s,5s,6e,8e,11z,26z)-4,5-dihydroxy-16λ⁵,22-diazahexacyclo[16.15.1.1¹,¹⁶.0²,²².0³,¹⁶.0³,¹⁹]pentatriaconta-6,8,11,26-tetraen-16-ylium-35-olate

C33H50N2O3 (522.3821)

1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-7-(n-methylbenzamido)-tetradecahydro-1h-cyclopenta[a]phenanthren-6-yl acetate

C33H50N2O3 (522.3821)

(6r,9ar,11as)-1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-7-(n-methylbenzamido)-tetradecahydro-1h-cyclopenta[a]phenanthren-6-yl acetate

C33H50N2O3 (522.3821)

n-{15-[1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}benzenecarboximidic acid

C33H50N2O3 (522.3821)

(1s,3as,3br,5as,7r,9as,9bs,11r,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-7-(n-methylbenzamido)-tetradecahydro-1h-cyclopenta[a]phenanthren-11-yl acetate

C33H50N2O3 (522.3821)

1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-7-(n-methylbenzamido)-tetradecahydro-1h-cyclopenta[a]phenanthren-11-yl acetate

C33H50N2O3 (522.3821)

(1s,3as,3bs,5ar,6r,7s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-7-(n-methylbenzamido)-tetradecahydro-1h-cyclopenta[a]phenanthren-6-yl acetate

C33H50N2O3 (522.3821)

n-[(1s,3r,6s,7r,8r,11s,12s,14r,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]benzenecarboximidic acid

n-[(1s,3r,6s,7r,8r,11s,12s,14r,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]benzenecarboximidic acid

C33H50N2O3 (522.3821)

(1s,3as,3bs,5ar,6r,7r,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-7-(n-methylbenzamido)-tetradecahydro-1h-cyclopenta[a]phenanthren-6-yl acetate

C33H50N2O3 (522.3821)